DK0759302T3 - Middel mod rheumatoid arthritis - Google Patents

Middel mod rheumatoid arthritis

Info

Publication number
DK0759302T3
DK0759302T3 DK95913319T DK95913319T DK0759302T3 DK 0759302 T3 DK0759302 T3 DK 0759302T3 DK 95913319 T DK95913319 T DK 95913319T DK 95913319 T DK95913319 T DK 95913319T DK 0759302 T3 DK0759302 T3 DK 0759302T3
Authority
DK
Denmark
Prior art keywords
remedy
rheumatoid arthritis
monoclonal antibody
antibody recognizing
arthritis
Prior art date
Application number
DK95913319T
Other languages
English (en)
Inventor
Tadashi Nishida
Sachiko Miyake
Ko Okumura
Hideo Yagita
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Application granted granted Critical
Publication of DK0759302T3 publication Critical patent/DK0759302T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95913319T 1994-04-26 1995-03-22 Middel mod rheumatoid arthritis DK0759302T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8825194 1994-04-26
PCT/JP1995/000527 WO1995028961A1 (fr) 1994-04-26 1995-03-22 Medicament pour polyarthrite rhumatoide

Publications (1)

Publication Number Publication Date
DK0759302T3 true DK0759302T3 (da) 2000-11-13

Family

ID=13937651

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95913319T DK0759302T3 (da) 1994-04-26 1995-03-22 Middel mod rheumatoid arthritis

Country Status (9)

Country Link
US (1) US5855888A (da)
EP (1) EP0759302B1 (da)
AT (1) ATE195428T1 (da)
DE (1) DE69518415T2 (da)
DK (1) DK0759302T3 (da)
ES (1) ES2151054T3 (da)
GR (1) GR3034200T3 (da)
PT (1) PT759302E (da)
WO (1) WO1995028961A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE347907T1 (de) * 1998-10-07 2007-01-15 Lennart Lindbom Anti-entzündliche alpha2, beta1 integrin- verwandte substanzen oder antikörper
HU226383B1 (hu) * 1999-04-22 2008-10-28 Biogen Idec Inc Eljárás fibrózis kezelésére az integrin alfa-4-alegységének antagonistájával
CN1309419C (zh) * 1999-06-01 2007-04-11 比奥根艾迪克Ma公司 Vla－1的单克隆封闭抗体及其应用
US6146639A (en) * 1999-07-26 2000-11-14 Merich Nick Arthritis, muscle pain, and dry skin remedy
DE60236735D1 (de) 2001-04-13 2010-07-29 Biogen Idec Inc Antikörper gegen vla-1
US20030013107A1 (en) * 2001-06-07 2003-01-16 Rigel Pharmaceuticals, Incorporated Alpha 2 integrin: modulators of lymphocyte activation
AP2809A (en) * 2005-11-18 2013-12-31 Glenmark Pharmaceuticals Sa Anti-Alpha2 Integrin antibodies and their uses
EP2839843B1 (en) * 2006-05-25 2018-06-20 Biogen MA Inc. VLA-1 antagonist for use in treating stroke
US20080267978A1 (en) * 2006-08-28 2008-10-30 Mary Zutter Anti-angiogenic targets for cancer therapy
AU2012255143A1 (en) 2011-05-19 2014-02-20 The Regents Of The University Of Michigan Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation
EP2814468B1 (en) 2012-02-16 2019-06-19 Santarus, Inc. Anti-vla1 (cd49a) antibody pharmaceutical compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0330506A3 (en) * 1988-02-26 1990-06-20 Dana Farber Cancer Institute Vla proteins
DK162890D0 (da) * 1990-07-06 1990-07-06 Novo Nordisk As Polypeptid
AU673499B2 (en) * 1991-07-25 1996-11-14 Biogen Idec Inc. Recombinant antibodies for human therapy

Also Published As

Publication number Publication date
ES2151054T3 (es) 2000-12-16
GR3034200T3 (en) 2000-11-30
ATE195428T1 (de) 2000-09-15
DE69518415T2 (de) 2001-01-25
PT759302E (pt) 2001-01-31
EP0759302B1 (en) 2000-08-16
DE69518415D1 (de) 2000-09-21
WO1995028961A1 (fr) 1995-11-02
EP0759302A4 (en) 1997-11-19
US5855888A (en) 1999-01-05
EP0759302A1 (en) 1997-02-26

Similar Documents

Publication Publication Date Title
DK0759302T3 (da) Middel mod rheumatoid arthritis
ITMI921522A0 (it) Apparato di lavaggio e sterilizzazione di tappi di gomma, o simili impiegabili in confezioni farmaceutiche
FI932958A (fi) Elastisk paose foer att packa in sammantryckbara produkter, speciellt sanitetsartiklar saosom bloejor, samt en foerpackning i vilken sammantryckta sanitetsprodukter foerpackats
NL300098I1 (nl) Thiophene sulfonamides useful as carbonic anhydrase inhibitors.
FI935443A (fi) Kabeltaetning
ATE138569T1 (de) Topisch anzuwendendes arzneimittel enthaltend ketoprofenlysinat
FI893159A (fi) Laite ja menetelmä terveydenhuollossa syntyvien ongelmajätteiden käsittelemiseksi
ATE113650T1 (de) Ausgewählte stämme von lactobacillus enthaltende pharmazeutische zusammensetzungen.
ES2145158T3 (es) Nueva formulacion de emulsion.
ZA969130B (en) Diagnostics and treatments of periodontal disease
BR9406292A (pt) Complexo de inclusão de taxol ou taxotere ou extrato de taxus formados com ciclodextrinas sua preparação e uso
ATE433339T1 (de) Parasympathikomimetikum und parasympathikolytikum enthaltendes tts
DE59104380D1 (de) Vorrichtung zum Bilden von Reihen und Lagen von Flaschen.
YU49422B (sh) Upotreba inhibitora ugljenične anhidraze za proizvodnju medikamenata za tretiranje makularnog edema ili makularne degeneracije izazvane starošću
ATE139226T1 (de) Aminosulfonylharnstoff-acat-inhibitoren
TNSN95055A1 (fr) Un article absorbant jetable-methode et appareillage pour sa fabrication
DK1146043T3 (da) Taxaner med en alkylsubstitueret sidekæde og farmaceutiske præparater indeholdende disse
FR2713444B1 (fr) Composition liquide désinfectante et ses utilisations.
ITRM910545A0 (it) Dispositivo trasportatore di bobine, rocche di filo e simili
ES2187618T3 (es) Utilizacion de compuestos de urea y de tiourea para la eliminacion o desintoxicacion de superantigenos de fluidos corporales.
KR950701812A (ko) 렌티바이러스-유도된 질환의 치료에 유용한 생물학적으로 활성인 우레이도 유도체(Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease)
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
FR2690330B1 (fr) Dispositif destine a traiter certaines fractures siegeant entre massif trochanterien et 1/3 moyen de la diaphyse femorale.
DK0826373T3 (da) Forebyggende middel mod postoperativ astigmatisme
ATE136469T1 (de) Neue verwendung eines monoklonalen antikörpers